Carastock.

Nov 14, 2023 · The company, currently valued at $57.32M, closed the recent trade at $1.06 per share which meant it lost -$0.12 on the day or -10.17% during that session. The CARA stock price is -1108.49% off its 52-week high price of $12.81 and 2.83% above the 52-week low of $1.03. If we look at the company’s 10-day average daily trading volume, we find ...

Carastock. Things To Know About Carastock.

Dec 1, 2023 · Cara Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of pruritus in the United States. The company’s lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults ... The current Cara Therapeutics [ CARA] share price is $1.09. The Score for CARA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal. CARA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.6 ngày trước ... KUPAS TUNTAS CARA STOCK OPNAME DENGAN TOKO BUKA AGAR TERHINDAR DENDA PAJAK! #shorts Opname stok toko terbuka adalah proses penghitungan dan ...Sep 13, 2023 · What's Happening with CARA Stock Today Cara Therapeutics Inc (CARA) stock has gained 5.52% while the S&P 500 has gained 0.24% as of 12:13 PM on Wednesday, Sep 13. CARA has gained $0.10 from the previous closing price of $1.72 on volume of 537,920 shares. Over the past year the S&P 500 has risen 13.73% while CARA is lower by -82.48%.

Cara Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery, development, and commercialization of novel therapeutics to treat serious medical conditions, including pruritus.Feb 26, 2016 10:50 AM EST. NEW YORK ( TheStreet) -- Cara Therapeutics ( CARA) - stock is down by 36.02% to $4.42 on heavy trading volume on Friday, after the FDA placed a trial for the company's ...Complete Cara Therapeutics Inc. stock information by Barron's. View real-time CARA stock price and news, along with industry-best analysis.

Stock analysis for Carasent ASA (CARA:Oslo) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Read more about CARA stock here. Cara Therapeutics's financial history has been pretty bad. The company has only turned a profit in one of the past nine years. Read more about CARA stock here.

585.00. +10.63%. 14.84M. View the real-time Cara Therapeutic (NASDAQ CARA) share price and assess historical data, charts, technical analysis and the share chat forum.Cara Therapeutics Inc (CARA) stock has fallen -6.06% while the S&P 500 has risen 0.34% as of 12:40 PM on Tuesday, Nov 7. CARA has fallen -$0.08 from the previous closing price of $1.33 on volume of 223,033 shares. Over the past year the S&P 500 has gained 15.08% while CARA has fallen -86.62%. CARA lost -$2.07 per share the …That is an increase of 297.20% in revenues from the year-ago report and is 79.93% lower than consensus estimates set at $16.3 million. The stock is down 29.89% to $7.03 after the report. The firm's higher revenue growth to earnings signals that the firm has not been able to reduce costs and has seen its profit margin decrease.Find the latest analyst research for Cara Therapeutics, Inc. Common Stock (CARA) at Nasdaq.com.Cara Therapeutics Inc (CARA) stock is trading at $5.51 as of 3:36 PM on Tuesday, Mar 21, a gain of $0.21, or 3.96% from the previous closing price of $5.30. The stock has traded between $5.31 and $5.53 so far today. Volume today is below average.

According to our current CARA stock forecast, the value of CARA Therapeutics shares will drop by -19.87% and reach $ 0.746314 per share by December 3, 2023. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear).

Get the latest Cara Therapeutics Inc. (CARA) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.

Cara Therapeutics Announces Positive Topline Results CARA: Cara Therapeutics, Inc. 2022-06-30 07:00:00 Cara Therapeutics Announces Positive Topline Results from KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Patients with Nostalgia Paresthetica CARA: Cara Therapeutics, Inc. 2022-06-30 07:00:00 Cara Therapeutics Announces Positive Topline Results from KOMFORT Phase ... eToro. Buy Stocks. On eToro’s Website. Get millions of investment ideas on eToro with the power of social investing. Explore over 2,500 stocks. Buy in bulk, or invest in fractional shares. eToro ...Pengertian Safety Stock. Safety stock adalah sejumlah persediaan barang yang disiapkan oleh sebuah perusahaan dalam menghadapi jumlah permintaan yang tidak pasti. Tujuannya adalah supaya ketika permintaan tinggi, perusahaan tersebut tidak kehabisan stok barang. Manajemen persediaan cadangan ini perlu dilakukan dengan …What's Happening with CARA Stock Today Cara Therapeutics Inc (CARA) stock is down -4.28% while the S&P 500 has gained 1.3% as of 12:31 PM on Wednesday, Apr 27. CARA is down -$0.45 from the previous closing price of $10.51 on volume of 212,841 shares. Over the past year the S&P 500 has gained 1.02% while CARA is down -61.46%.Cara Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of pruritus in the United States. The company’s lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults ...Trailing 12-Months. Asset Growth. -40.69%. Trailing 12-Months. Cara Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven ... Cara Therapeutics Inc (NASDAQ: CARA) shares dive after as investors react to topline results from its KARE Phase 2 trial evaluating oral Korsuva (difelikefalin tablets) for the treatment of ...

What is the CARA Therapeutics stock forecast? · CARA Therapeutics stock prediction for 1 year from now: $ 7.69 (625.24%) · CARA Therapeutics stock forecast for ...Dec 1, 2023 · View Cara Therapeutics, Inc CARA investment & stock information. Get the latest Cara Therapeutics, Inc CARA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Cara Therapeutics (CARA) (Delayed Data from NSDQ) $1.10 USD +0.01 (0.92%) Updated Nov 17, 2023 03:59 PM ET After-Market: $1.11 +0.01 (0.91%) 7:58 PM ET Add to portfolio Zacks Rank: 4-Sell 4 Style...Cara Therapeutics Inc Follow Share $1.06 After Hours: $1.02 (3.77%) -0.040 Closed: Dec 1, 7:55:45 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Adicet Bio Inc $1.23 ACET4.24% Tilray Brands...Cara Therapeutics Inc (CARA) stock is higher by 5.42% while the S&P 500 is lower by -0.08% as of 1:37 PM on Thursday, Apr 7. CARA has risen $0.69 from the previous closing price of $12.73 on volume of 256,141 shares. Over the past year the S&P 500 is higher by 9.75% while CARA is lower by -49.42%.

Cara Therapeutics Inc (CARA) stock is trading at $6.33 as of 3:12 PM on Thursday, Mar 9, a drop of -$0.09, or -1.33% from the previous closing price of $6.41. Volume today is more active than usual. So far 850,368 shares have traded compared to average volume of 621,904 shares. The stock has traded between $6.24 and $6.71 so …Cara Therapeutics Inc Cara Therapeutics Inc CARA Morningstar Rating Unlock Stock XNAS Rating as of Nov 29, 2023 Summary Chart News Sustainability Trailing Returns Financials Valuation $0.96 −0.02...

The firm currently boasts a market capitalization value of $187.83 million alongside a price-earnings ratio of -2.23 and beta of 0.87. Nonetheless, with exponential growth attainable through various regulatory approvals, the research-based biopharmaceutical company appears primed to deliver cutting-edge solutions that resonate in today’s ...Overview. Founded in 2004 with headquarters in Connecticut (84 employees), Cara Therapeutics currently sports an enterprise value of ~$350M and Q2 cash position of $204M providing them operational ...Cara Therapeutics (CARA) Options Chain & Prices. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Get daily stock ideas from top-performing Wall Street analysts.Research Reports. SEC Filings. Insider Monkey. Get the latest Cara Therapeutics, Inc. (CARA) stock news and headlines to help you in your trading and investing decisions.Find the latest Cara Therapeutics, Inc. (CARA) stock quote, history, news and other vital information to help you with your stock trading and investing.6 ngày trước ... KUPAS TUNTAS CARA STOCK OPNAME DENGAN TOKO BUKA AGAR TERHINDAR DENDA PAJAK! #shorts Opname stok toko terbuka adalah proses penghitungan dan ...Overview. Founded in 2004 with headquarters in Connecticut (84 employees), Cara Therapeutics currently sports an enterprise value of ~$350M and Q2 cash position of $204M providing them operational ...Find out all the key statistics for Cara Therapeutics, Inc. (CARA), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.Find out the direct holders, institutional holders and mutual fund holders for Cara Therapeutics, Inc. (CARA).Cara Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery, development, and commercialization of novel therapeutics to treat serious medical conditions, including pruritus.

Cara Therapeutics Stock Earnings. The value each CARA share was expected to gain vs. the value that each CARA share actually gained. Cara Therapeutics ( CARA) reported Q3 2023 earnings per share (EPS) of -$0.52, meeting estimates of -$0.52 by 0.60%. In the same quarter last year, Cara Therapeutics 's earnings per share (EPS) was -$0.43.

Sector Industry Market Cap Revenue; Medical: Medical - Biomedical and Genetics: $0.058B: $0.042B: Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain.

What's Happening with CARA Stock Today. Cara Therapeutics Inc (CARA) stock is down -3.55% while the S&P 500 is down -0.28% as of 2:22 PM on Thursday, Oct 19. CARA is down -$0.05 from the previous closing price of $1.41 on volume of 234,874 shares. Over the past year the S&P 500 is higher by 16.43% while CARA is down -86.11%.Top price targets Weekly price targets Monthly price targets Yearly price targets Intraday price targets . As on 19 Mon Sep 2022 Current price of Cara Therapeutics, Inc. CARA is 9.84 and trend of stock is towards upside and stock can be bought for price targets of 10.27, 10.41, 10.52, 10.6, 10.62, 11.68, 10.82Dec 1, 2023 · Who is on Cara Therapeutics's Insider Roster? The list of insiders at Cara Therapeutics includes Christopher Posner, Derek T Chalmers, Frederique Ph.D. Menzaghi, Jeffrey L Ives, Joana Goncalves, Martin Vogelbaum, Scott Terrillion, and Thomas Charles Reilly. Learn more on insiders at CARA. Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus.Mar 10, 2023 · As of March 10, 2023, 4:00 PM CST, Cara Therapeutics Inc’s stock price was $6.06. Cara Therapeutics Inc is down 5.16% from its previous closing price of $6.39. During the last market session, Cara Therapeutics Inc’s stock traded between $6.24 and $6.71. Currently, there are 53.76 million shares of Cara Therapeutics Inc stock available for ... Cara Therapeutics, Inc. ( NASDAQ:CARA ) shareholders will have a reason to smile today, with the analysts making... Find the latest Cara Therapeutics, Inc. (CARA) stock quote, history, news and other vital information to help you with your stock trading and investing.Mar 29, 2023 · What's Happening with CARA Stock Today. Cara Therapeutics Inc (CARA) stock is higher by 2.07% while the S&P 500 is higher by 1.41% as of 3:38 PM on Wednesday, Mar 29. CARA is higher by $0.10 from the previous closing price of $4.94 on volume of 309,020 shares. Over the past year the S&P 500 is down -13.05% while CARA has fallen -58.65%. Please wait. CARA's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing.Cara Therapeutics, Inc. Common Stock (CARA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Download stock pictures of Cara on Depositphotos ✓ Photo stock for commercial use - millions of high-quality, royalty-free photos & images.Nov 7, 2023 · Cara Therapeutics Inc (CARA) stock has fallen -6.06% while the S&P 500 has risen 0.34% as of 12:40 PM on Tuesday, Nov 7. CARA has fallen -$0.08 from the previous closing price of $1.33 on volume of 223,033 shares. Over the past year the S&P 500 has gained 15.08% while CARA has fallen -86.62%. CARA lost -$2.07 per share the over the last 12 months.

Thinking of buying or selling Cara Therapeutic stock that’s listed in a currency different from your local one? Use our international stock ticker to check and convert stocks and shares easily in any currency you need.Analysts Offer Insights on Healthcare Companies: CureVac (CVAC), MoonLake Immunotherapeutics (MLTX) and Cara Therapeutics (CARA) November 14, 2023TipRanks. Cara shares ‘highly disconnected ...This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of Cara Therapeutics, Inc. is based on the most popular technical indicators, such as Moving Averages, Oscillators and Pivots. Learn more. 1 minute.Instagram:https://instagram. nyse lmt compareauto trade botvalue of 1964 nicklestock vgt Cara Therapeutics, Inc. (CARA) stock forecast and price target Find the latest Cara Therapeutics, Inc. CARA analyst stock forecast, price target, and recommendation trends with in-depth analysis ...Find the latest analyst research for Cara Therapeutics, Inc. Common Stock (CARA) at Nasdaq.com. news ww3average cost hospital stay per day Cara Therapeutics Inc (CARA) stock is down -4.28% while the S&P 500 has gained 1.3% as of 12:31 PM on Wednesday, Apr 27. CARA is down -$0.45 from the previous closing price of $10.51 on volume of 212,841 shares. Over the past year the S&P 500 has gained 1.02% while CARA is down -61.46%. CARA lost -$1.74 per share in the over the …Shutterstock is a global marketplace for artists and creators to sell royalty-free images, footage, vectors and illustrations. We want to see the world through your eyes. gas prices drop 13 thg 11, 2023 ... CARA Stock Data. Industry Pharmaceutical Preparation Manufacturing. Sector Manufacturing. Website Link. Tags Health Technology, Biotechnology ...Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After Hours trades will be posted from 4:15 p ...Stock analysis for Cara Therapeutics Inc (CARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.